Automated Neural Dosing for Fast-Acting Subperception Therapy: Sustained Spinal Cord Stimulation Outcomes from a Multicenter Study.
Richard Ferro, James North, Andy Kranenburg...
https://pubmed.ncbi.nlm.nih.gov/40603812/Actively Recruiting
Led by Boston Scientific Corporation · Updated on 2026-10-09
15000
Participants Needed
145
Research Sites
N/A
Total Duration
This research aims to review anonymous medical records to study the clinical outcomes of various treatments for chronic pain. It is a retrospective, multi-center data review that includes multiple patient groups to evaluate different treatment approaches. The study focuses on patients who have been implanted with or are eligible for spinal cord stimulation systems or other treatments such as radiofrequency RF or intrathecal drug delivery systems IDS. The study compares different treatment methods, including Boston Scientific devices and non-Boston Scientific systems like spinal cord stimulation, RF, and IDS. It involves two groups patients eligible for these treatments and those who have received a prior treatment followed by a different chronic pain therapy. This evaluation uses de-identified data collected from medical charts without direct patient intervention. Participants involvement consists of reviewing their past medical data over approximately two years. Researchers will measure the responder rate, which indicates the effectiveness of the treatments through the study period. Since this is a data review, there are no active treatments or visits required, and patient privacy is maintained throughout the study.
CONDITIONS
Patient Retrospective Outcomes (PRO)
A
Alison Lewis
C
Cleo Mertz
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Boston Scientific Corporation
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Richard Ferro, James North, Andy Kranenburg...
https://pubmed.ncbi.nlm.nih.gov/40603812/Clark Metzger, Blake Hammond, Richard Ferro...
https://pubmed.ncbi.nlm.nih.gov/39819320/Boston Scientific Corporation
Lead Sponsor